Kannalife, a subsidiary of Neuropathix, Inc. (OTCQB: NPTX), is a biopharmaceutical company focused on the research and development of a pipeline of next generation cannabinoid-inspired therapeutics as potent, non-opioid alternatives to treat patients with significant unmet medical needs.